Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Spectral Medical Inc. (OTC: EDTXF).

Full DD Report for EDTXF

You must become a subscriber to view this report.


Recent News from (OTC: EDTXF)

Why CytoSorbents And Spectral Medical Inc Are Not Good Stocks For A Long Position
CytoSorbents and Spectral Medical Inc. are two medical device companies that have much in common. One is based in US and the other in Canada. CytoSorbents is in the business of reducing ICU deaths from fatal inflammation. Spectral Medical Inc. is in the business of treating sepsis , &...
Source: SeekingAlpha
Date: August, 04 2017 08:26
The Reasons Why Spectral Medical's Sepsis Treatment Will Not Receive An FDA Approval
More than 100 randomized clinical trials have been conducted in the hopes of finding a safe and effective treatment for sepsis . In 2011, Eli Lilly (LLY) withdrew its previously approved sepsis drug, Xigris, from all markets after the drug, approved a decade previously with a statistically ...
Source: SeekingAlpha
Date: July, 23 2017 06:21
Spectral Voluntarily Delists From OTCQX
TORONTO, ONTARIO--(Marketwired - Dec. 14, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT)(OTCQX:EDTXF) , a Phase III company developing the first treatment for patients with endotoxemic septic shock using a medical device, today announced that after a detailed review...
Source: Marketwired
Date: December, 14 2016 08:00
Spectral Announces Appointment of Dr. Masayuki Kaneko to Its Board of Directors
TORONTO, ONTARIO--(Marketwired - Dec. 5, 2016) - Spectral   Medical   Inc.   ("Spectral"   or   the "Company") (TSX:EDT) (OTCQX:EDTXF) a Phase III company developing the first treatment for patients with endotoxemic septic shock using a medical device, today an...
Source: Marketwired
Date: December, 05 2016 08:00
Spectral Diagnostics reports Q3 results
Spectral Diagnostics ( OTCQX:EDTXF ): Q3 EPS of -C$0.01 More news on: Spectral Medical Inc., Earnings news and commentary, Financial stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 11 2016 08:08
Spectral Announces Next Steps in Path Forward and Issues Third Quarter Results
TORONTO, ONTARIO--(Marketwired - Nov. 11, 2016) - Spectral Medical Inc., (TSX:EDT) (OTCQX:EDTXF) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced next steps in its development program for Toraymyxin™...
Source: Marketwired
Date: November, 11 2016 08:00
Spectral Announces Clinical Trial Results
TORONTO, ONTARIO--(Marketwired - Oct. 3, 2016) -   Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT)(OTCQX:EDTXF) a Phase III company developing the first treatment for patients with endotoxemic septic shock using a medical device, today announced the top line results o...
Source: Marketwired
Date: October, 03 2016 08:03
Spectral Responds to Recent Trading Activity
TORONTO, ONTARIO--(Marketwired - Sept. 20, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) (OTCQX:EDTXF) , at the request of IIROC on behalf of the Toronto Stock Exchange, confirms that as of the date of this news release, they are not aware of any corporate developm...
Source: Marketwired
Date: September, 20 2016 14:05
Spectral Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
TORONTO, ONTARIO--(Marketwired - Sept. 7, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT)(OTCQX:EDTXF) a Phase III Company advancing a precision treatment targeting specific patients at high risk of death from endotoxemic septic shock, today announced it will be fea...
Source: Marketwired
Date: September, 07 2016 08:00
Spectral Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
Spectral Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
Source: OTC Markets
Date: September, 07 2016 00:00

 


About Spectral Medical Inc. (OTC: EDTXF)

Logo for Spectral Medical Inc. (OTC: EDTXF)

Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment of septic shock. Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. Directed by the Company s Endotoxin Activity Assay EAA , the only FDA cleared diagnostic for the risk of developing sepsis, Spectral s EUPHRATES trial is the world s first theranostics trial in the area of sepsis.

 

Contact Information

 

 

Current Management

  • Paul M. Walker / President, CEO
  • Anthony Businskas / EVP, CFO, IR
  • Debra M. Foster / VP, Clinical Development
  • Anthony Bihl III / Chairman
  • Anthony Businskas /
  • Kevin Giese /
  • Guillermo Herrera /
  • William Stevens /
  • Koichiro Takeshita /
  • Paul M. Walker /

Current Share Structure

  • Market Cap: $65,990,085 - 03/09/2018
  • Authorized: 212,414,709 - 03/31/2016
  • Issue and Outstanding: 206,865,470 - 09/30/2016

 


Recent Filings from (OTC: EDTXF)

Supplemental Information - CFO CERTIFICATION OF INTERIM FILINGS
Filing Type: Supplemental Information - CFO CERTIFICATION OF INTERIM FILINGSFiling Source: OTC Markets
Filing Date: November, 11 2016
Supplemental Information - CEO Certificate CERTIFICATION OF INTERIM FILINGS
Filing Type: Supplemental Information - CEO Certificate CERTIFICATION OF INTERIM FILINGSFiling Source: OTC Markets
Filing Date: November, 11 2016
Interim Financial Report - Condensed Interim Consolidated Financial Statements
Filing Type: Interim Financial Report - Condensed Interim Consolidated Financial StatementsFiling Source: OTC Markets
Filing Date: November, 11 2016
Supplemental Information - CFO - CERTIFICATION OF INTERIM FILINGS
Filing Type: Supplemental Information - CFO - CERTIFICATION OF INTERIM FILINGSFiling Source: OTC Markets
Filing Date: August, 12 2016
Supplemental Information - CEO - CERTIFICATION OF INTERIM FILINGS
Filing Type: Supplemental Information - CEO - CERTIFICATION OF INTERIM FILINGSFiling Source: OTC Markets
Filing Date: August, 12 2016
Interim Financial Report - Condensed Interim Consolidated Financial Statements
Filing Type: Interim Financial Report - Condensed Interim Consolidated Financial StatementsFiling Source: OTC Markets
Filing Date: August, 12 2016
Proxy Materials - Report of Voting Results
Filing Type: Proxy Materials - Report of Voting ResultsFiling Source: OTC Markets
Filing Date: June, 01 2016
Supplemental Information - CERTIFICATION OF INTERIM FILINGS - CFO
Filing Type: Supplemental Information - CERTIFICATION OF INTERIM FILINGS - CFOFiling Source: OTC Markets
Filing Date: May, 12 2016

 

 


Daily Technical Chart for (OTC: EDTXF)

Daily Technical Chart for (OTC: EDTXF)


Stay tuned for daily updates and more on (OTC: EDTXF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: EDTXF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EDTXF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of EDTXF and does not buy, sell, or trade any shares of EDTXF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/